Charles Y. Chiu, MD, PhD

Global Health Sciences Faculty Affiliate

Phone: 415-514-8219
UCSF Box: 0134
Email: charles.chiu@ucsf.edu
UCSF Profile

Project Sponsor Location(s) Topics Start End
Metagenomics for Detection and Discovery of Viruses Associated with Acute Gastroenteritis in Mexico University of California Institute for Mexico and the U.S. (UC MEXUS) Mexico Drug and Diagnostics Development
Identification of Viruses in an Asthma Cohort Genentech, Inc. United States Chronic Respiratory Disease, Drug and Diagnostics Development
Metagenomics for Identification of Infectious Triggers of KLS Kleine-Levin Syndrome Foundation, Inc. United States Drug and Diagnostics Development
Virus Detection Using Microarrays and Characterization of a Novel Cardiovirus NIH National Institute of Allergy and Infectious Disease United States Drug and Diagnostics Development
To Discover and Characterize Novel Viruses in Cancer Global Viral Forecasting Initiative United States Infectious Disease, Cancer/Oncology
Viral Discovery in Human and Animal Samples Global Viral Forecasting Initiative Rwanda; Uganda; Tanzania; Cameroon; Congo (Kinshasa); Congo (Brazzaville); Gabon; China; Bangladesh; Nepal; Cambodia; Indonesia; Viet Nam; Laos; Malaysia; Thailand; Mexico; Bolivia; Brazil; Peru; United States Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Using Pan-Pathogen Microarrays and Deep Sequencing to Search for the Cause of Southern Tick-Associated Rash Illness (STARI) National Research Fund for Tick-Borne Disease United States Zoonosis, Emerging Disease, and Drug Resistance
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens NIH National Institute of Allergy and Infectious Disease Africa; India; Mexico; Canada; United States Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Comprehensive Diagnostics for Viral Encephalitis/Meningitis Abbott Laboratories United States Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Multiplexed Viral and Cytokine Response Assays Using NanoString Technology Lawrence Livermore National Laboratory United States Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Pathogen Discovery in PREDICT Human and Wildlife samples to Detect and Identify Viruses Present, Both Known and Novel Global Viral Forecasting Initiative China; Bangladesh; Indonesia; Malaysia; Mexico; Brazil; Colombia Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Clin 0004 Characterization of Viral Hemorrhagic Fevers of Unknown Origin Global Viral Forecasting Initiative Cameroon; Central African Republic; Congo (Kinshasa); Congo (Brazzaville); Gabon Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Clin 0003 Identification and Characterization of a Putative Novel Poxvirus in the DRC Global Viral Forecasting Initiative Congo (Kinshasa) Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
CCD Study- RNA Sequencing University of British Columbia Infectious Disease, Drug and Diagnostics Development
Pathogen characterization and discovery by deep sequencing of two major vectors associated with Lyme disease and other tickborne infections Lyme Research Alliance, Inc United States Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Establishing a Core Facility for Virus Detection and Discovery Abbott Laboratories United States Drug and Diagnostics Development, Epidemiology and Surveillance
Comprehensive Diagnostics for Viral Encephalitis/Meningitis UC Discovery-Biotechnology United States Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing NIH National Heart, Lung, and Blood Institute United States Infectious Disease, Drug and Diagnostics Development
Whole Blood/Serum Samples from Patients with Hepatitis NIH National Heart, Lung, and Blood Institute United States Infectious Disease, Drug and Diagnostics Development
Real-Time Detection of Bloodborne Pathogens by Unbiased Nanopore Sequencing 20150506 United States Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Tissue Biopsy Samples from Head and Neck Cancers Yamaguchi University Japan Cancer/Oncology, Drug and Diagnostics Development
Serological prevalence of viral hemorrhagic fevers in Equatorial Africa Blood Systems Research Institute Cameroon; Central African Republic; Congo (Kinshasa); Congo (Brazzaville); Equatorial Guinea; Gabon Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Metabiota - Viral Surveillance for the PREDICT Program 20150410 Metabiota, Inc Rwanda; Uganda; Tanzania; Cameroon; Congo (Kinshasa); Congo (Brazzaville); Gabon; China; Bangladesh; Nepal; Cambodia; Indonesia; Viet Nam; Laos; Malaysia; Thailand; Mexico; Bolivia; Brazil; Peru Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Development of the infant gastrointestinal virome and shedding of oral polio and rotavirus vaccines in Bangladeshi and US infants Stanford University Bangladesh Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Newborn and Infant Health
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing NIH National Institute of Allergy and Infectious Disease Congo (Kinshasa); Congo (Brazzaville); Brazil Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development